SCHEMBL21019482

SCHEMBL21019482

C=CNCc1ccc(-c2ccc(-c3ccc(C)cc3)c(F)c2F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
GLA P06280 1/20 0.40
NPC1 O15118 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 5/20 0.35
LMNA P02545 4/20 0.35
CHRM2 P08172 1/20 0.34
MEN1 O00255 3/20 0.34
HPGD P15428 3/20 0.34
AURKA O14965 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
LCK P06239 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
MET P08581 1/20 0.33
PDGFRB P09619 1/20 0.33
PIM1 P11309 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21696535 0.83 SMN1; SMN2 (0.46) ALDH1A1GLANPC1SMN1; SMN2KMT2A
SCHEMBL803252 0.79 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL16803055 0.76 FFAR4 (0.37) CYP3A4CYP2C9CYP2C19PTGS2KDM4E
SCHEMBL19633940 0.76 CHKA (0.35)
SCHEMBL172423 0.75 ACHE (0.48) NPC1SMN1; SMN2KMT2AMEN1MAPK14
SCHEMBL12140863 0.74 LMNA (0.38) NPC1SMN1; SMN2LMNAMAPK14CYP2C19
SCHEMBL26046596 0.74 PTGS2 (0.38) NPC1AURKAABL1NTRK1LCK
SCHEMBL17570168 0.73 ACHE (0.46) MAPK14PTGS2
SCHEMBL23373028 0.73 ADH1B (0.42) ALDH1A1SMN1; SMN2KMT2AMEN1L3MBTL1
SCHEMBL13249626 0.73 ALDH1A1 (0.42) ALDH1A1NPC1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230053362-A1 DICHROIC DYE COMPOSITION MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
US-20220025265-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2022-01-27 US disclosed
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2022-01-18 US disclosed
US-20210348056-A1 Polymerisable Compounds and the Use thereof in Liquid-Crystal Displays MERCK PATENT GMBH (DE) 2021-11-11 US disclosed
US-11168257-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2021-11-09 US disclosed
US-20210284912-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2021-09-16 US disclosed
US-20210277310-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2021-09-09 US disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
US-10982150-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2021-04-20 US disclosed
US-10934487-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2021-03-02 US disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
US-20200157427-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2020-05-21 US disclosed
US-20200040257-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2020-02-06 US disclosed
US-20190345389-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-11-14 US disclosed
US-20190316037-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-10-17 US disclosed
US-20190284474-A1 SWITCHING LAYER FOR USE IN AN OPTICAL SWITCHING ELEMENT MERCK PATENT GMBH (DE) 2019-09-19 US disclosed
US-20190264105-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2019-08-29 US disclosed
US-20190256777-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2019-08-22 US disclosed
US-20190241811-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-08-08 US disclosed
US-20190153320-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays VCL, PLEC, EML4 ALDH1A1 4429/4885GLA 1271/4885NPC1 3628/4885
US-20210284912-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY CXCR1, PYM1, F11 ALDH1A1 2963/4885GLA 2191/4885NPC1 345/4885
US-20190256777-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 ALDH1A1 4429/4885GLA 1271/4885NPC1 3628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.